Home | Register | Login | Inquiries | Alerts | Sitemap |  


Advanced Search
JKM > Volume 42(2); 2021 > Article
Kim: Korean medicine treatment including oral administration of Gyejibongnyeong-hwan and acupuncture therapy for calf edema and pain due to deep vein thrombosis of lower leg: A Case Report

Abstract

Objectives

This study was aimed to report changes in clinical symptoms and signs after treatment with Korean medicine in patients who suffered from calf edema due to deep vein thrombosis (DVT).

Methods

A 46-year-old male patient, who discharged home after receiving standardized treatment for acute DVT in the right leg, suffered pain and heat sense due to edema of the affected calf. Oral administration of herbal medicine (Gyejibongnyeong-hwan 4 g, twice daily) and acupuncture therapy were given to him for 6 weeks. The change in chief complaints, Villalta score, the right and left side difference of the circumference and the skin surface temperature of both calves, and blood level of D-dimer were observed before and after treatment.

Results

The patient’s chief complaints began to significantly improve from 2 weeks after treatment, and disappeared completely within 4 weeks. At the end of the treatment, a substantial decrease in the difference between the right and left calves in the circumference and skin surface temperature was observed. This effect was maintained even at the time of follow-up 3 months after the end of treatment, and the patient completely recovered indoor and outdoor life to the level before onset.

Conclusions

This case suggests that Korean medicine treatment, including Gyejibongnyeong-hwan administration and acupuncture therapy, can be a viable option to improve edema and related clinical problems in the affected limbs due to DVT.

Notes

Conflicts of interest

이 논문은 이해관계 충돌의 여지가 없음.

Acknowledgement

증례 보고를 위한 자료 제공에 동의하고 적극적으로 협조해 주신 환자분께 감사드립니다.

Fig. 1
Change of verbal numeric rating scales for pain and heat sensation
Verbal numeric scale: 0–10 points, 10 = pain or heat sensation at week 0
Week 0 = initiation of Korean medicine treatment
jkm-42-2-107f1.gif
Fig. 2
Change of digital infrared thermal imaging (DITI) of lower extremity
Left: original image, right: left-right symmetry
(A) Taken at week 0 (initiation of Korean medicine treatment)
(B) Taken at week 3
(C) Taken at week 6
jkm-42-2-107f2.gif
Table 1
The difference in the circumference of both calves and presence of non-pitting edema in right calf
Domain/week 0 1 2 3 4 5 6
Circumference 1 (fibular head) 1.5 1.5 1.0 0.5 0.5 0.2 0.2
Circumference 2 (maximal circumference) 1.5 1.7 1.0 0.8 0.5 0.5 0.5
Non-pitting edema, right calf + + +/− +/− - - -

Circumference (right calf – left calf, cm)

Fibula head: The circumference was measured based on the acupoint GB34.

Maximal circumference: The circumference was measured based on the point where the calf was thickest.

Week 0 = initiation of Korean medicine treatment

Table 2
Change of Villalta score and D-dimer level
Outcome / week −1 0 1 2 3 4 5 6 15
Villalta score (points) - 10 11 7 5 3 1 1 -
D-dimer (mg/L) 8.7 - - 2.4 - - - - 0.4

Week 0 = initiation of the Korean medicine treatment

Villalta score (range: 0–33 points; the higher, the more severe)

D-dimer level (reference range < 0.65 mg/L)

참고문헌

1. Flinterman LE, van Hylckama Vlieg A, Cannegieter SC, Rosendaal FR. Long-term survival in a large cohort of patients with venous thrombosis: incidence and predictors. PLoS Med. 2012; 9:1. e1001155
crossref pmid pmc

2. Kim MU, Choi SY, Hwang JY. The Diagnosis and Interventional Treatment of Deep Vein Thrombosis. J Korean Soc Radiol. 2018; 78:6. 363–70.
crossref

3. Chen C, Tang Q, Zhang W, Yuan H, Huai Y, Jiang K, et al. Combination of Traditional Chinese Medicine and Low-Molecular-Weight Heparin Prevents Deep Vein Thrombosis After Surgery: A Meta. Analysis Clin Appl Thromb Hemost. 2019; 25:1076029619890411
crossref pmid

4. Zhu S, Song Y, Chen X, Qian W. Traditional Chinese and western medicine for the prevention of deep venous thrombosis after lower extremity orthopedic surgery: a meta-analysis of randomized controlled trials. J Orthop Surg Res. 2018; 13:1. 79
crossref pmid pmc

5. Huang H, Pan J, Han Y, Zeng L, Liang G, Yang W, et al. Chinese Herbal Medicines for Promoting Blood Circulation and Removing Blood Stasis in Preventing Deep Venous Thrombosis after Total Hip Arthroplasty: A Systematic Review and Meta-Analysis. Comb Chem High Throughput Screen. 2020; (E-pub Ahead of Print). 10.2174/1386207323666200901103732.


6. Kang J-s, Park S-h, Song M-k, Ahn Y-m, Ahn S-y, Lee B-c. The Effect of Hyulbuchuko-tang on a Case with Deep Vein Thrombosis (DVT) and Intracranial Hemorrhage( ICH). Korean J Orient Int Med. 2009; 30:2. 438–49.


7. Kim T-H, Kim H-H, Hong S-I, Lim E-C. A Clinical Study on Soyangin Lower Limb Edema Caused by Deep Vein Thrombosis. J of Sasang Constitutional Medicine. 2006; 18:3. 202–9.


8. Sul JU, Shin MS, Choi JB. Clinical Investigation about Suspected the DVT(Deep Vein Thrombosis): Case Report. J Korean Med Rehabi. 2004; 14:2. 137–45.


9. Bae G-e, Choi J-y, Shim S-h, Seo H-j, Seo H-b, Hong J-w, et al. A Case Report of a Patient with Subarachnoid Hemorrhage and Deep Vein Thrombosis Treated with a Combination of East-West Medicine. J Int Korean Med. 2018; 39:2. 165–75.
crossref

10. Kim HT, Choi KE, Oh JM, Heo JW, Eom TM, Cho MK, et al. Case of Deep Vein Thrombosis Patient Treated by Korean Medicine. Korean J Orient Physiol & Pathol. 2015; 29:6. 503–9.
crossref

11. Kahn SR, Partsch H, Vedantham S, Prandoni P, Kearon C, et al. Scientific SoCoAot. Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization. J Thromb Haemost. 2009; 7:5. 879–83.
crossref pmid

12. Heit JA, O’Fallon WM, Petterson TM, Lohse CM, Silverstein MD, Mohr DN, et al. Relative Impact of Risk Factors for Deep Vein Thrombosis and Pulmonary Embolism: A Population-Based Study. Arch Intern Med. 2002; 162:11. 1245–8.
crossref pmid

13. Nazarzadeh M, Pinho-Gomes AC, Mohseni H, Byrne KS, Bidel Z, Dehghan A, et al. Blood Pressure and Risk of Venous Thrombolism. A Large-Scale Prospective Cohort Analysis and a Mendelian Randomisation Study. J Hypertens Suppl. 2019; 37:e95
crossref

14. Gaborit FS, Overvad K, Nørgaard M, Kristensen SR, Tjønneland A, Severinsen MT. Alcohol intake and risk of venous thromboembolism. Thromb Haemost. 2013; 110:07. 39–45.
crossref pmid

15. Cheng Y-J, Liu Z-H, Yao F-J, Zeng W-T, Zheng D-D, Dong Y-G, et al. Current and former smoking and risk for venous thromboembolism: a systematic review and meta-analysis. PLoS Med. 2013; 10:9. e1001515
crossref pmid pmc

16. Cushman M, Tsai AW, White RH, Heckbert SR, Rosamond WD, Enright P, et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med. 2004; 117:1. 19–25.
crossref pmid

17. White RH. The epidemiology of venous thromboembolism. Circulation. 2003; 107:23 Suppl 1. I4–8.
crossref pmid

18. Kyrle PA, Eichinger S. Deep vein thrombosis. The Lancet. 2005; 365:9465. 1163–74.
crossref

19. Rabinovich A, Kahn SR. How I treat the postthrombotic syndrome. Blood. 2018; 131:20. 2215–22.
crossref pmid

20. Kahn SR, Comerota AJ, Cushman M, Evans NS, Ginsberg JS, Goldenberg NA, et al. The Postthrombotic Syndrome: Evidence-Based Prevention, Diagnosis, and Treatment Strategies. Circulation. 2014; 130:18. 1636–61.
crossref pmid

21. Villalta S, Bagatella P, Piccioli A, Lensing A, Prins M, Prandoni P. Assessment of validity and reproducibility of a clinical scale for the post-thrombotic syndrome. Haemostasis. 1994; 24:suppl 1. 158a


22. Engeseth M, Enden T, Sandset PM, Wik HS. Predictors of long-term post-thrombotic syndrome following high proximal deep vein thrombosis: a cross-sectional study. Thromb J. 2021; 19:1. 3
crossref pmid pmc

23. Kahn SR, Shrier I, Julian JA, Ducruet T, Arsenault L, Miron MJ, et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med. 2008; 149:10. 698–707.
crossref pmid

24. Cosmi B, Legnani C, Tosetto A, Pengo V, Ghirarduzzi A, Testa S, et al. Comorbidities alone and in combination with D-dimer, as risk factors for recurrence after a first episode of unprovoked venous thromboembolism in the extended follow-up of the PROLONG study. Thromb Haemost. 2010; 103:06. 1152–60.
crossref pmid

25. Deng F, Tang Q, Zeng G, Wu H, Zhang N, Zhong N. Effectiveness of digital infrared thermal imaging in detecting lower extremity deep venous thrombosis. Med Phys. 2015; 42:5. 2242–8.
crossref pmid

26. Leung L. Neurophysiological Basis of Acupuncture-induced Analgesia—An Updated Review. J Acupunct Meridian Stud. 2012; 5:6. 261–70.
crossref pmid

27. Sandberg M, Lundeberg T, Lindberg L-G, Gerdle B. Effects of acupuncture on skin and muscle blood flow in healthy subjects. Eur J Appl Physiol. 2003; 90:1. 114–9.
crossref pmid

28. Kim B-J, Kim Y-K, Park W-H, Ko J-H, Lee Y-C, Kim C-H. A water-extract of the Korean traditional formulation Geiji–Bokryung–Hwan reduces atherosclerosis and hypercholesteremia in cholesterol-fed rabbits. Int Immunopharmacol. 2003; 3:5. 723–34.
crossref pmid

29. Terawaki K, Noguchi M, Yuzurihara M, Omiya Y, Ikarashi Y, Kase Y. Keishibukuryogan, a Traditional Japanese Medicine, Inhibits Platelet Aggregation in Guinea Pig Whole Blood. Evid Based Complement Alternat Med. 2015; 2015:295706
crossref pmid pmc

30. Goto H, Shimada Y, Sekiya N, Yang Q, Kogure T, Mantani N, et al. Effects of Keishi-bukuryo-gan on vascular function and hemorheological factors in spontaneously diabetic (WBN/kob) rats. Phytomedicine. 2004; 11:2–3. 188–95.
crossref pmid

31. Hayashi S, Shibutani S, Okubo H, Shimogawara T, Ichinose T, Ito Y, et al. Examination of Clinical Efficacy of Keishibukuryogan on Non-Specific Complaints Associated with Varicose Veins of the Lower Extremity. Ann Vasc Dis. 2014; 7:3. 266–73.
crossref pmid pmc

32. Fujita K, Yamamoto T, Kamezaki T, Matsumura A. Efficacy of Keishibukuryogan, a Traditional Japanese Herbal Medicine, in Treating Cold Sensation and Numbness After Stroke: Clinical Improvement and Skin Temperature Normalization in 22 Stroke Patients. Neurol Med Chir (Tokyo). 2010; 50:1. 1–6.
crossref pmid

33. Uchida N. A Randomized Controlled Trial of the Chinese Herbal Medicine Keisi-bukuryogan (Gui-Zhi-Fu-Ling-Wan) in the Treatment of Deep Vein Thrombosis. The Japanese Journal of Phlebology. 2009; 20:1. 1–6.


34. Li GM. Evaluation for Efficacy of Guizhi Fuling Pill combined with Rivaroxaban in treating Deep Venous Thrombosis of cerebral arterial thrombosis. Clinical Journal of Traditional Chinese Medicine. 2019; 31:7. 1371–4.


TOOLS
PDF Links  PDF Links
Full text via DOI  Full text via DOI
PubReader  PubReader
Download Citation  Download Citation
  E-Mail
  Print
Share:      
METRICS
0
Crossref
81
View
11
Download
Editorial office contact information
3F, #26-27 Gayang-dong, Gangseo-gu Seoul, 157-200 Seoul, Korea
The Society of Korean Medicine
Tel : +82-2-2658-3627   Fax : +82-2-2658-3631   E-mail : skom1953@daum.net
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Developed in M2PI